Nabriva Therapeutics Prices Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Nabriva Therapeutics AG (NBRV) IPO Opens Up 8%
September 18, 2015 11:24 AM EDTToday's IPO for Nabriva Therapeutics AG (NASDAQ: NBRV) opened for trading at $11.39 after pricing 9,000,000 American Depositary Shares (ADSs), representing 900,000 of its common shares, at a public offering price of $10.25 per ADS. The pricing was a smidge below the expected... More
Nabriva Therapeutics AG (NBRV) IPO Prices at $10.25/ADS, Slightly Below Expectations
September 18, 2015 8:46 AM EDTNabriva Therapeutics AG (NASDAQ: NBRV) announced he pricing of its initial public offering of 9,000,000 American Depositary Shares (ADSs), representing 900,000 of its common shares, at a public offering price of $10.25 per ADS. The pricing was a smidge below the expected $10.50/ADS. Shares are... More
